Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients - PubMed (original) (raw)
Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients
H-J Epple et al. Gut. 2009 Feb.
Abstract
Background and aims: Impairment of the gastrointestinal mucosal barrier contributes to progression of HIV infection. The purpose of this study was to investigate the effect of highly active antiretroviral therapy (HAART) on the HIV-induced intestinal barrier defect and to identify underlying mechanisms.
Methods: Epithelial barrier function was characterised by impedance spectroscopy and [(3)H]mannitol fluxes in duodenal biopsies from 11 untreated and 8 suppressively treated HIV-infected patients, and 9 HIV-seronegative controls. The villus/crypt ratio was determined microscopically. Epithelial apoptoses were analysed by terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labelling (TUNEL) and caspase-3 staining. Tight junction protein expression was quantified by densitometric analysis of immunoblots. Mucosal cytokine production was determined by cytometric bead array.
Results: Only in untreated but not in treated HIV-infected patients, epithelial resistance was reduced (13 (1) vs 23 (2) ohm cm(2), p<0.01) and mannitol permeability was increased compared with HIV-negative controls (19 (3) vs 9 (1) nm/s, p<0.05). As structural correlates, epithelial apoptoses and expression of the pore-forming claudin-2 were increased while expression of the sealing claudin-1 was reduced in untreated compared with treated patients and HIV-negative controls. Furthermore, villous atrophy was evident and mucosal production of interleukin 2 (IL2), IL4 and tumour necrosis factor alpha (TNFalpha) was increased in untreated but not in treated HIV-infected patients. Incubation with IL2, IL4, TNFalpha and IL13 reduced the transepithelial resistance of rat jejunal mucosa.
Conclusions: Suppressive HAART abrogates HIV-induced intestinal barrier defect and villous atrophy. The HIV-induced barrier defect is due to altered tight junction protein composition and elevated epithelial apoptoses. Mucosal cytokines are mediators of the HIV-induced mucosal barrier defect and villous atrophy.
Similar articles
- Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment.
Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Zeissig S, et al. Gut. 2004 Sep;53(9):1295-302. doi: 10.1136/gut.2003.036632. Gut. 2004. PMID: 15306588 Free PMC article. - Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. Heller F, et al. Gastroenterology. 2005 Aug;129(2):550-64. doi: 10.1016/j.gastro.2005.05.002. Gastroenterology. 2005. PMID: 16083712 - Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect.
Epple HJ, Allers K, Tröger H, Kühl A, Erben U, Fromm M, Zeitz M, Loddenkemper C, Schulzke JD, Schneider T. Epple HJ, et al. Gastroenterology. 2010 Oct;139(4):1289-300. doi: 10.1053/j.gastro.2010.06.065. Epub 2010 Jun 27. Gastroenterology. 2010. PMID: 20600014 - HIV infection and the intestinal mucosal barrier.
Epple HJ, Zeitz M. Epple HJ, et al. Ann N Y Acad Sci. 2012 Jul;1258:19-24. doi: 10.1111/j.1749-6632.2012.06512.x. Ann N Y Acad Sci. 2012. PMID: 22731711 Review. - Epithelial tight junctions in intestinal inflammation.
Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Schulzke JD, et al. Ann N Y Acad Sci. 2009 May;1165:294-300. doi: 10.1111/j.1749-6632.2009.04062.x. Ann N Y Acad Sci. 2009. PMID: 19538319 Review.
Cited by
- Gut-bacteria derived membrane vesicles and host metabolic health: a narrative review.
Verbunt J, Jocken J, Blaak E, Savelkoul P, Stassen F. Verbunt J, et al. Gut Microbes. 2024 Jan-Dec;16(1):2359515. doi: 10.1080/19490976.2024.2359515. Epub 2024 May 29. Gut Microbes. 2024. PMID: 38808455 Free PMC article. Review. - Severe intestinal barrier damage in HIV-infected immunological non-responders.
Guo XY, Guo YT, Wang ZR, Jiao YM, Hu Y, Fan LN, Cheng RQ, Qu MM, Zhang C, Song JW, Xu RN, Fan X, Xu W, Zhang JY, Bai BK, Linghu EQ, Chen YK, Ma P, Wang FS. Guo XY, et al. Heliyon. 2023 Oct 12;9(10):e20790. doi: 10.1016/j.heliyon.2023.e20790. eCollection 2023 Oct. Heliyon. 2023. PMID: 37876458 Free PMC article. - The metabolic consequences of HIV/TB co-infection.
Herbert C, Luies L, Loots DT, Williams AA. Herbert C, et al. BMC Infect Dis. 2023 Aug 18;23(1):536. doi: 10.1186/s12879-023-08505-4. BMC Infect Dis. 2023. PMID: 37592227 Free PMC article. - Macromolecule Translocation across the Intestinal Mucosa of HIV-Infected Patients by Transcytosis and through Apoptotic Leaks.
Krug SM, Grünhagen C, Allers K, Bojarski C, Seybold J, Schneider T, Schulzke JD, Epple HJ. Krug SM, et al. Cells. 2023 Jul 18;12(14):1887. doi: 10.3390/cells12141887. Cells. 2023. PMID: 37508551 Free PMC article. - Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease.
Gabriel CL, Ferguson JF. Gabriel CL, et al. Circ Res. 2023 Jun 9;132(12):1674-1691. doi: 10.1161/CIRCRESAHA.123.322055. Epub 2023 Jun 8. Circ Res. 2023. PMID: 37289901 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous